HP and gastric cancer: Conversely, the statistically significant rise in sPGII levels (by 80%, PAdjusted < 0.0001) and drop in sPGI/II ratio (by 30%, PAdjusted < 0.0001) were only observed in the Hp-positive healthy subjects, but not in GC patients in this age group.